Auxilium Pharmaceuticals (AUXL) moves up 23.1% premarket after announcing positive top-line...


Auxilium Pharmaceuticals (AUXL) moves up 23.1% premarket after announcing positive top-line results in testing on the use of its Xiaflex drug in treating Peyronie's disease.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs